PMID: 9433334Jan 20, 1998Paper

Use of ECT for the inpatient treatment of recurrent major depression

The American Journal of Psychiatry
M OlfsonH A Pincus

Abstract

The authors' goals were to determine the frequency and distribution of ECT for general hospital inpatients with recurrent major depression and to estimate the effects of prompt ECT on the length and cost of inpatient care. Data from the 1993 Healthcare Cost and Utilization Project were analyzed to determine the rate of ECT use for adult inpatients with a principal discharge diagnosis of major depression, recurrent. Associations between prompt initial use of ECT (in the first 5 hospital days) and length and cost of inpatient care were examined before and after control for sociodemographic, diagnostic, and hospital organizational characteristics. An estimated 9.4% of general hospital adult inpatients with a principal diagnosis of recurrent major depression received ECT in the survey year. A majority (59.2%) of these received their initial ECT session within the first 5 days after hospital admission. In univariate analyses, the likelihood of receiving ECT was greater for older patients, whites, privately insured individuals, and patients who lived in more affluent areas. Patients who received ECT tended to have relatively long and costly admissions. After control for several demographic, diagnostic, and hospital organizational cha...Continue Reading

Citations

Dec 3, 2014·Clinics in Geriatric Medicine·Mijung Park, Charles F Reynolds
Apr 23, 2003·Biological Psychiatry·Anthony J Rothschild
Dec 21, 2011·The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry·Audrey M van SchaikMax L Stek
Jan 13, 2016·BJPsych Bulletin·Nesif AlhemiaryMohammed J Abbas
Jun 29, 2012·Brain and Behavior·Kari Ann LeiknesBjørg Høie
Jul 17, 2013·Asia-Pacific Psychiatry : Official Journal of the Pacific Rim College of Psychiatrists·Nien-Mu ChiuWen-Kuei Lee
Feb 25, 2000·Biological Psychiatry·M S GeorgeJ C Ballenger
Jan 9, 2001·The Psychiatric Clinics of North America·M S GeorgeA J Rush
Jan 28, 2004·Biological Psychiatry·Joan PrudicHarold A Sackeim
May 16, 2000·Journal of the American Geriatrics Society·K G Kelly, M Zisselman
Apr 4, 2001·Psychiatry and Clinical Neurosciences·K F Chung, S J Wong
Dec 21, 2007·Schizophrenia Bulletin·Joyce C WestMark Olfson
Mar 1, 2012·The Australian and New Zealand Journal of Psychiatry·Chris PlakiotisDaniel W O'Connor
Apr 30, 2014·Neuropsychiatry·Nancy Kerner, Joan Prudic
Jun 19, 2003·Journal of the American Medical Directors Association·M H ZisselmanS J Denman
Oct 13, 2009·Journal of Psychiatric Practice·Nancy A Payne, Joan Prudic
Jun 27, 2002·Journal of Geriatric Psychiatry and Neurology·Ilkka KujalaSvein Ivar Bekkelund
Jun 2, 2017·The Journal of ECT·Uros RakitaPeter Giacobbe
Jul 29, 2008·Harvard Review of Psychiatry·Hesham M Hamoda, David N Osser
Sep 23, 2000·Journal of Clinical Psychopharmacology·J A Wheeler VegaP J Tyson
May 16, 2009·The Journal of ECT·Worrawat ChanpattanaChittaranjan Andrade
Jul 18, 2018·Journal of Psychiatric Practice·Maria I LapidSimon Kung
Aug 30, 2005·The Journal of ECT·Serene P C TehDeirdre G Drake
Aug 30, 2005·The Journal of ECT·Alexander I Nelson
Nov 22, 2018·The Journal of ECT·Paul A DennisNora M Dennis
Apr 20, 2013·Schizophrenia Bulletin·Anthony J Rothschild
Feb 4, 2014·Journal of Mental Health·Maede Ejaredar, Brad Hagen
Mar 29, 2002·European Psychiatry : the Journal of the Association of European Psychiatrists·M PhilpotL Gustafson

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved